Skip to main content
Top
Published in: Current Rheumatology Reports 7/2021

01-07-2021 | ANCA-Associated Vasculitis | Vasculitis (C Dejaco and C Duftner, Section Editors)

The Nasal Microbiome in ANCA-Associated Vasculitis: Picking the Nose for Clues on Disease Pathogenesis

Authors: G. J. Dekkema, A. Rutgers, J. S. Sanders, C. A. Stegeman, P. Heeringa

Published in: Current Rheumatology Reports | Issue 7/2021

Login to get access

Abstract

Purpose of Review

The onset and progression of small vessel vasculitis associated with anti-neutrophil cytoplasmic antibodies has been linked to microbial infections. Here, we provide a brief overview of the association of nasal colonization of Staphylococcus aureus with ANCA-associated vasculitis (AAV) and discuss several recent studies mapping the nasal microbiome in AAV patients in particular.

Recent Findings

Nasal microbiome studies revealed dysbiosis as a common trait in active AAV which tends to normalize upon immunosuppressive treatment and quiescent disease. However, due to differences in study design, patient selection, and methodology, the reported microbiome profiles differ considerably precluding conclusions on causal relationships.

Summary

The microbiome is an emerging area of research in AAV warranting further investigation. Ideally, such studies should be combined with mechanistic studies to unravel key elements related to host-microbe interactions and their relevance for AAV pathogenesis.
Literature
1.
go back to reference Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219–32.CrossRef Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219–32.CrossRef
2.
go back to reference Manasson J, Blank RB, Scher JU. The microbiome in rheumatology: where are we and where should we go? Ann Rheum Dis. 2020;79(6):727–33.CrossRef Manasson J, Blank RB, Scher JU. The microbiome in rheumatology: where are we and where should we go? Ann Rheum Dis. 2020;79(6):727–33.CrossRef
3.
go back to reference Konig MF. The microbiome in autoimmune rheumatic disease. Best Pract Res Clin Rheumatol. 2020;34(1):101473.CrossRef Konig MF. The microbiome in autoimmune rheumatic disease. Best Pract Res Clin Rheumatol. 2020;34(1):101473.CrossRef
4.••
go back to reference Kitching AR, Anders HJ, Basu N, et al. ANCA-associated vasculitis. Nat Rev Dis Primers. 2020;6(1):71-020-0204-y Most comprehensive review on ANCA-associated vasculitis to date. Kitching AR, Anders HJ, Basu N, et al. ANCA-associated vasculitis. Nat Rev Dis Primers. 2020;6(1):71-020-0204-y Most comprehensive review on ANCA-associated vasculitis to date.
5.
go back to reference Lyons PA, Rayner TF, Trivedi S, et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med. 2012;367(3):214–23.CrossRef Lyons PA, Rayner TF, Trivedi S, et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med. 2012;367(3):214–23.CrossRef
6.
go back to reference Rahmattulla C, Mooyaart AL, van Hooven D, et al. Genetic variants in ANCA-associated vasculitis: a meta-analysis. Ann Rheum Dis. 2016;75(9):1687–92.CrossRef Rahmattulla C, Mooyaart AL, van Hooven D, et al. Genetic variants in ANCA-associated vasculitis: a meta-analysis. Ann Rheum Dis. 2016;75(9):1687–92.CrossRef
7.
go back to reference Holme SS, Kilian K, Eggesbø HB, Moen JM, Molberg Ø. Impact of baseline clinical and radiological features on outcome of chronic rhinosinusitis in granulomatosis with polyangiitis. Arthritis Res Ther. 2021;23(1):18-020-02401-x.CrossRef Holme SS, Kilian K, Eggesbø HB, Moen JM, Molberg Ø. Impact of baseline clinical and radiological features on outcome of chronic rhinosinusitis in granulomatosis with polyangiitis. Arthritis Res Ther. 2021;23(1):18-020-02401-x.CrossRef
8.
go back to reference Stegeman CA, Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CG. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in wegener granulomatosis. Ann Intern Med. 1994;120(1):12–7.CrossRef Stegeman CA, Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CG. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in wegener granulomatosis. Ann Intern Med. 1994;120(1):12–7.CrossRef
9.
go back to reference Laudien M, Gadola SD, Podschun R, et al. Nasal carriage of Staphylococcus aureus and endonasal activity in wegener s granulomatosis as compared to rheumatoid arthritis and chronic rhinosinusitis with nasal polyps. Clin Exp Rheumatol. 2010;28(1 Suppl 57):51–5.PubMed Laudien M, Gadola SD, Podschun R, et al. Nasal carriage of Staphylococcus aureus and endonasal activity in wegener s granulomatosis as compared to rheumatoid arthritis and chronic rhinosinusitis with nasal polyps. Clin Exp Rheumatol. 2010;28(1 Suppl 57):51–5.PubMed
10.
go back to reference van Timmeren MM, Heeringa P, Kallenberg CG. Infectious triggers for vasculitis. Curr Opin Rheumatol. 2014;26(4):416–23.CrossRef van Timmeren MM, Heeringa P, Kallenberg CG. Infectious triggers for vasculitis. Curr Opin Rheumatol. 2014;26(4):416–23.CrossRef
11.
go back to reference Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener’s granulomatosis. Dutch co-trimoxazole Wegener study group. N Engl J Med. 1996;335(1):16–20.CrossRef Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener’s granulomatosis. Dutch co-trimoxazole Wegener study group. N Engl J Med. 1996;335(1):16–20.CrossRef
12.
go back to reference Salmela A, Rasmussen N, Tervaert JWC, Jayne DRW, Ekstrand A, European Vasculitis Study Group. Chronic nasal Staphylococcus aureus carriage identifies a subset of newly diagnosed granulomatosis with polyangiitis patients with high relapse rate. Rheumatology (Oxford). 2017;56(6):965–72.CrossRef Salmela A, Rasmussen N, Tervaert JWC, Jayne DRW, Ekstrand A, European Vasculitis Study Group. Chronic nasal Staphylococcus aureus carriage identifies a subset of newly diagnosed granulomatosis with polyangiitis patients with high relapse rate. Rheumatology (Oxford). 2017;56(6):965–72.CrossRef
13.
go back to reference Tan BK, Crabol Y, Tasse J, et al. No evident association of nasal carriage of Staphylococcus aureus or its small-colony variants with cotrimoxazole use or ANCA-associated vasculitis relapses. Rheumatology (Oxford). 2020;59(1):77–83.CrossRef Tan BK, Crabol Y, Tasse J, et al. No evident association of nasal carriage of Staphylococcus aureus or its small-colony variants with cotrimoxazole use or ANCA-associated vasculitis relapses. Rheumatology (Oxford). 2020;59(1):77–83.CrossRef
14.
go back to reference Glasner C, van Timmeren MM, Stobernack T, et al. Low anti-staphylococcal IgG responses in granulomatosis with polyangiitis patients despite long-term Staphylococcus aureus exposure. Sci Rep. 2015;5:8188.CrossRef Glasner C, van Timmeren MM, Stobernack T, et al. Low anti-staphylococcal IgG responses in granulomatosis with polyangiitis patients despite long-term Staphylococcus aureus exposure. Sci Rep. 2015;5:8188.CrossRef
15.
go back to reference Glasner C, de Goffau MC, van Timmeren MM, et al. Genetic loci of Staphylococcus aureus associated with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides. Sci Rep. 2017;7(1):12211-017-12450-z. Glasner C, de Goffau MC, van Timmeren MM, et al. Genetic loci of Staphylococcus aureus associated with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides. Sci Rep. 2017;7(1):12211-017-12450-z.
16.
go back to reference Pendergraft WF 3rd, Preston GA, Shah RR, et al. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med. 2004;10(1):72–9.CrossRef Pendergraft WF 3rd, Preston GA, Shah RR, et al. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med. 2004;10(1):72–9.CrossRef
17.
go back to reference Tadema H, Abdulahad WH, Lepse N, Stegeman CA, Kallenberg CG, Heeringa P. Bacterial DNA motifs trigger ANCA production in ANCA-associated vasculitis in remission. Rheumatology (Oxford). 2011;50(4):689–96.CrossRef Tadema H, Abdulahad WH, Lepse N, Stegeman CA, Kallenberg CG, Heeringa P. Bacterial DNA motifs trigger ANCA production in ANCA-associated vasculitis in remission. Rheumatology (Oxford). 2011;50(4):689–96.CrossRef
18.
go back to reference Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532–5.CrossRef Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532–5.CrossRef
19.
go back to reference Sangaletti S, Tripodo C, Chiodoni C, et al. Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity. Blood. 2012;120(15):3007–18.CrossRef Sangaletti S, Tripodo C, Chiodoni C, et al. Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity. Blood. 2012;120(15):3007–18.CrossRef
20.
go back to reference Kessenbrock K, Krumbholz M, Schönermarck U, et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med. 2009;15(6):623–5.CrossRef Kessenbrock K, Krumbholz M, Schönermarck U, et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med. 2009;15(6):623–5.CrossRef
21.•
go back to reference Ooi JD, Jiang JH, Eggenhuizen PJ, et al. A plasmid-encoded peptide from Staphylococcus aureus induces anti-myeloperoxidase nephritogenic autoimmunity. Nat Commun. 2019;10(1):3392-019-11255-0 Study suggesting molecular mimicry as a mechanism explaining the association between S. aureus and ANCA vasculitides by demonstrating that a S. aureus peptide, homologous to an immunodominant MPO T cell epitope (MPO409–428), induces anti-MPO autoimmunity. Ooi JD, Jiang JH, Eggenhuizen PJ, et al. A plasmid-encoded peptide from Staphylococcus aureus induces anti-myeloperoxidase nephritogenic autoimmunity. Nat Commun. 2019;10(1):3392-019-11255-0 Study suggesting molecular mimicry as a mechanism explaining the association between S. aureus and ANCA vasculitides by demonstrating that a S. aureus peptide, homologous to an immunodominant MPO T cell epitope (MPO409–428), induces anti-MPO autoimmunity.
22.
go back to reference Oliveira DBG. Linked help from bacterial proteins drives autoantibody production in small vessel vasculitis. Med Hypotheses. 2018;112:24–6.CrossRef Oliveira DBG. Linked help from bacterial proteins drives autoantibody production in small vessel vasculitis. Med Hypotheses. 2018;112:24–6.CrossRef
23.
go back to reference Stapels DA, Ramyar KX, Bischoff M, et al. Staphylococcus aureus secretes a unique class of neutrophil serine protease inhibitors. Proc Natl Acad Sci U S A. 2014;111(36):13187–92.CrossRef Stapels DA, Ramyar KX, Bischoff M, et al. Staphylococcus aureus secretes a unique class of neutrophil serine protease inhibitors. Proc Natl Acad Sci U S A. 2014;111(36):13187–92.CrossRef
24.
go back to reference de Jong NWM, Ramyar KX, Guerra FE, et al. Immune evasion by a staphylococcal inhibitor of myeloperoxidase. Proc Natl Acad Sci U S A. 2017;114(35):9439–44.CrossRef de Jong NWM, Ramyar KX, Guerra FE, et al. Immune evasion by a staphylococcal inhibitor of myeloperoxidase. Proc Natl Acad Sci U S A. 2017;114(35):9439–44.CrossRef
25.
go back to reference Cui Z, Zhao MH, Segelmark M, Hellmark T. Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals. Kidney Int. 2010;78(6):590–7.CrossRef Cui Z, Zhao MH, Segelmark M, Hellmark T. Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals. Kidney Int. 2010;78(6):590–7.CrossRef
26.
go back to reference Tadema H, Kallenberg CG, Stegeman CA, Heeringa P. Reactivity against complementary proteinase-3 is not increased in patients with PR3-ANCA-associated vasculitis. PLoS One. 2011;6(3):e17972.CrossRef Tadema H, Kallenberg CG, Stegeman CA, Heeringa P. Reactivity against complementary proteinase-3 is not increased in patients with PR3-ANCA-associated vasculitis. PLoS One. 2011;6(3):e17972.CrossRef
27.
go back to reference Lepse N, Land J, Rutgers A, et al. Toll-like receptor 9 activation enhances B cell activating factor and interleukin-21 induced anti-proteinase 3 autoantibody production in vitro. Rheumatology (Oxford). 2016;55(1):162–72.CrossRef Lepse N, Land J, Rutgers A, et al. Toll-like receptor 9 activation enhances B cell activating factor and interleukin-21 induced anti-proteinase 3 autoantibody production in vitro. Rheumatology (Oxford). 2016;55(1):162–72.CrossRef
28.
go back to reference Hurtado PR, Jeffs L, Nitschke J, et al. CpG oligodeoxynucleotide stimulates production of anti-neutrophil cytoplasmic antibodies in ANCA associated vasculitis. BMC Immunol. 2008;9:34-2172-9-34.CrossRef Hurtado PR, Jeffs L, Nitschke J, et al. CpG oligodeoxynucleotide stimulates production of anti-neutrophil cytoplasmic antibodies in ANCA associated vasculitis. BMC Immunol. 2008;9:34-2172-9-34.CrossRef
29.
go back to reference Popa ER, Stegeman CA, Abdulahad WH, et al. Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener’s granulomatosis. Rheumatology (Oxford). 2007;46(6):1029–33.CrossRef Popa ER, Stegeman CA, Abdulahad WH, et al. Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener’s granulomatosis. Rheumatology (Oxford). 2007;46(6):1029–33.CrossRef
30.••
go back to reference Krebs CF, Reimers D, Zhao Y, et al. Pathogen-induced tissue-resident memory T(H)17 (T(RM)17) cells amplify autoimmune kidney disease. Sci Immunol. 2020;5(50):eaba4163. https://doi.org/10.1126/sciimmunol.aba4163Study showing that tissue-resident memory T cells with Th17 characteristics are abundant in kidney biopsies of AAV patients with renal involvement. In mice, these TRM17 cells can be induced by S. aureus infection and aggravate renal pathology in a model of crescentic glomerulonephritis. Krebs CF, Reimers D, Zhao Y, et al. Pathogen-induced tissue-resident memory T(H)17 (T(RM)17) cells amplify autoimmune kidney disease. Sci Immunol. 2020;5(50):eaba4163. https://​doi.​org/​10.​1126/​sciimmunol.​aba4163Study showing that tissue-resident memory T cells with Th17 characteristics are abundant in kidney biopsies of AAV patients with renal involvement. In mice, these TRM17 cells can be induced by S. aureus infection and aggravate renal pathology in a model of crescentic glomerulonephritis.
31.
go back to reference Konig MF, Andrade F. A critical reappraisal of neutrophil extracellular traps and NETosis mimics based on differential requirements for protein citrullination. Front Immunol. 2016;7:461.PubMedPubMedCentral Konig MF, Andrade F. A critical reappraisal of neutrophil extracellular traps and NETosis mimics based on differential requirements for protein citrullination. Front Immunol. 2016;7:461.PubMedPubMedCentral
32.
go back to reference Konstantinov KN, Ulff-Møller CJ, Tzamaloukas AH. Infections and antineutrophil cytoplasmic antibodies: triggering mechanisms. Autoimmun Rev. 2015;14(3):201–3.CrossRef Konstantinov KN, Ulff-Møller CJ, Tzamaloukas AH. Infections and antineutrophil cytoplasmic antibodies: triggering mechanisms. Autoimmun Rev. 2015;14(3):201–3.CrossRef
33.
go back to reference Land J, Rutgers A, Kallenberg CG. Anti-neutrophil cytoplasmic autoantibody pathogenicity revisited: pathogenic versus non-pathogenic anti-neutrophil cytoplasmic autoantibody. Nephrol Dial Transplant. 2014;29(4):739–45.CrossRef Land J, Rutgers A, Kallenberg CG. Anti-neutrophil cytoplasmic autoantibody pathogenicity revisited: pathogenic versus non-pathogenic anti-neutrophil cytoplasmic autoantibody. Nephrol Dial Transplant. 2014;29(4):739–45.CrossRef
34.••
go back to reference Rhee RL, Sreih AG, Najem CE, et al. Characterisation of the nasal microbiota in granulomatosis with polyangiitis. Ann Rheum Dis. 2018;77(10):1448–53 First study to describe the nasal microbiota in granulomatosis with polyangiitis (GPA) patients using culture-independent techniques. Indicates normalization of the nasal microbiome upon immunosuppression and disease quiescence. Rhee RL, Sreih AG, Najem CE, et al. Characterisation of the nasal microbiota in granulomatosis with polyangiitis. Ann Rheum Dis. 2018;77(10):1448–53 First study to describe the nasal microbiota in granulomatosis with polyangiitis (GPA) patients using culture-independent techniques. Indicates normalization of the nasal microbiome upon immunosuppression and disease quiescence.
35.
go back to reference Wagner J, Harrison EM, Martinez Del Pero M, et al. The composition and functional protein subsystems of the human nasal microbiome in granulomatosis with polyangiitis: a pilot study. Microbiome. 2019;7(1):137-019-0753-z.CrossRef Wagner J, Harrison EM, Martinez Del Pero M, et al. The composition and functional protein subsystems of the human nasal microbiome in granulomatosis with polyangiitis: a pilot study. Microbiome. 2019;7(1):137-019-0753-z.CrossRef
36.
go back to reference Lamprecht P, Fischer N, Huang J, et al. Changes in the composition of the upper respiratory tract microbial community in granulomatosis with polyangiitis. J Autoimmun. 2019;97:29–39.CrossRef Lamprecht P, Fischer N, Huang J, et al. Changes in the composition of the upper respiratory tract microbial community in granulomatosis with polyangiitis. J Autoimmun. 2019;97:29–39.CrossRef
37.••
go back to reference Rhee RL, Lu J, Bittinger K, et al. Dynamic changes in the nasal microbiome associated with disease activity in patients with granulomatosis with polyangiitis. Arthritis Rheumatol. 2021. https://doi.org/10.1002/art.41723. Online ahead of print. First study investigating changes in microbiome composition over time in GPA patients suggesting a potential role for a disbalance in Staphylococcaceae and Corynebacteriaceae prior to relapse. Rhee RL, Lu J, Bittinger K, et al. Dynamic changes in the nasal microbiome associated with disease activity in patients with granulomatosis with polyangiitis. Arthritis Rheumatol. 2021. https://​doi.​org/​10.​1002/​art.​41723. Online ahead of print. First study investigating changes in microbiome composition over time in GPA patients suggesting a potential role for a disbalance in Staphylococcaceae and Corynebacteriaceae prior to relapse.
38.•
go back to reference Fukui S, Morimoto S, Ichinose K, et al. Comparison of lung microbiota between antineutrophil cytoplasmic antibody-associated vasculitis and sarcoidosis. Sci Rep. 2020;10(1):9466-020-66178-4 First study investigating pulmonary microbiota in AAV patients suggesting that pulmonary microbiome diversity is inversely correlated to disease status. Fukui S, Morimoto S, Ichinose K, et al. Comparison of lung microbiota between antineutrophil cytoplasmic antibody-associated vasculitis and sarcoidosis. Sci Rep. 2020;10(1):9466-020-66178-4 First study investigating pulmonary microbiota in AAV patients suggesting that pulmonary microbiome diversity is inversely correlated to disease status.
39.
go back to reference Najem E, Lee J, Tanes C, Shreih A, Rhee R, Geara A, et al. Defining the gut microbiome in patients with ANCA-associated vasculitis. Arthritis Rheumatol. 2018;70(Suppl. 9):abstract# 906. Najem E, Lee J, Tanes C, Shreih A, Rhee R, Geara A, et al. Defining the gut microbiome in patients with ANCA-associated vasculitis. Arthritis Rheumatol. 2018;70(Suppl. 9):abstract# 906.
40.
go back to reference Lina G, Boutite F, Tristan A, Bes M, Etienne J, Vandenesch F. Bacterial competition for human nasal cavity colonization: role of staphylococcal agr alleles. Appl Environ Microbiol. 2003;69(1):18–23.CrossRef Lina G, Boutite F, Tristan A, Bes M, Etienne J, Vandenesch F. Bacterial competition for human nasal cavity colonization: role of staphylococcal agr alleles. Appl Environ Microbiol. 2003;69(1):18–23.CrossRef
41.
go back to reference Frank DN, Feazel LM, Bessesen MT, Price CS, Janoff EN, Pace NR. The human nasal microbiota and Staphylococcus aureus carriage. PLoS One. 2010;5(5):e10598.CrossRef Frank DN, Feazel LM, Bessesen MT, Price CS, Janoff EN, Pace NR. The human nasal microbiota and Staphylococcus aureus carriage. PLoS One. 2010;5(5):e10598.CrossRef
42.
go back to reference Ullrich S, Gustke H, Lamprecht P, et al. Severe impaired respiratory ciliary function in Wegener granulomatosis. Ann Rheum Dis. 2009;68(6):1067–71.CrossRef Ullrich S, Gustke H, Lamprecht P, et al. Severe impaired respiratory ciliary function in Wegener granulomatosis. Ann Rheum Dis. 2009;68(6):1067–71.CrossRef
43.
go back to reference Laudien M, Dressel S, Harder J, Gläser R. Differential expression pattern of antimicrobial peptides in nasal mucosa and secretion. Rhinology. 2011;49(1):107–11.CrossRef Laudien M, Dressel S, Harder J, Gläser R. Differential expression pattern of antimicrobial peptides in nasal mucosa and secretion. Rhinology. 2011;49(1):107–11.CrossRef
44.
go back to reference Dimitri-Pinheiro S, Soares R, Barata P. The microbiome of the nose-friend or foe? Allergy Rhinol (Providence). 2020;11:2152656720911605.CrossRef Dimitri-Pinheiro S, Soares R, Barata P. The microbiome of the nose-friend or foe? Allergy Rhinol (Providence). 2020;11:2152656720911605.CrossRef
Metadata
Title
The Nasal Microbiome in ANCA-Associated Vasculitis: Picking the Nose for Clues on Disease Pathogenesis
Authors
G. J. Dekkema
A. Rutgers
J. S. Sanders
C. A. Stegeman
P. Heeringa
Publication date
01-07-2021
Publisher
Springer US
Published in
Current Rheumatology Reports / Issue 7/2021
Print ISSN: 1523-3774
Electronic ISSN: 1534-6307
DOI
https://doi.org/10.1007/s11926-021-01015-9

Other articles of this Issue 7/2021

Current Rheumatology Reports 7/2021 Go to the issue

Inflammatory Muscle Disease (L Diederichsen and H Chinoy, Section Editor)

Bone Health in Idiopathic Inflammatory Myopathies: Diagnosis and Management

Vasculitis (C Dejaco and C Duftner, Section Editors)

Localized Forms of Vasculitis

Inflammatory Muscle Disease (L Diederichsen and H Chinoy, Section Editor)

Updates on the Immunopathology in Idiopathic Inflammatory Myopathies

Systemic Lupus Erythematosus (G Tsokos, Section Editor)

Updates on Clinical Trials in Systemic Lupus Erythematosus

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.